Bound antibodies were detected using the enhanced chemiluminescent substrate (ECL, Pierce, Rockford, IL, USA)
The World Anti-Doping Agency (WADA), which regulates the drugs and other substances that elite athletes are allowed to take in and out of competition, banned the peptide in 2022 because BPC-157, according to its website, lacks current approval by any governmental regulatory health authority for human therapeutic use. But despite that regulatory action, trainers admit that they still work with elite and pro athletes who choose to take the peptide during downtime to speed recovery from injuries and surgerieswith relatively little fear of repercussions
Post-procedure and wound healing compounds
Research has confirmed that the peptide lacks the systemic effects of growth hormone, showing no impact on IGF-1 levels, glucose metabolism, or growth-promoting effects in other tissues